Moderate Immunohistochemical Expression of HER-2 (2+) Without HER-2 Gene Amplification Is a Negative Prognostic Factor in Early Breast Cancer

JOURNAL ARTICLE published 1 November 2012 in The Oncologist

Authors: Valentina Rossi | Ivana Sarotto | Furio Maggiorotto | Paola Berchialla | Franziska Kubatzki | Nicoletta Tomasi | Stefania Redana | Rossella Martinello | Giorgio Valabrega | Massimo Aglietta | Riccardo Ponzone | Filippo Montemurro